An observational study in Traumatic Brain Injury and Self Efficacy, sponsored by Rehabilitation Hospital of Indiana. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-25.
Sponsored by Rehabilitation Hospital of Indiana · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 909 studies in Brain Injuries, Traumatic with a site in United States — 212 open to participants now, 250 under way, 5 of them phase 3. Brain Injuries, Traumatic · United States.
Among the 909 studies in Brain Injuries, Traumatic with a site in United States, this one is the 112th largest by enrollment of the 257 observational ones that give a count, is one of 53 that started in 2019, is one of 258 observational ones, and was the 554th registered.
1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.
Browse Brain Injuries, Traumatic studies →212 of the 909 studies in Brain Injuries, Traumatic with a site in United States are open now. Recruiting first, the newest first:
Shirley Ryan AbilityLab · Sites in United States
Ages 18–75
Andrew Mayer · Sites in United States
Ages 18–82 · Healthy volunteers
Johns Hopkins University · Sites in United States
Ages 18–55
Columbia University · Sites in United States
Ages 18+
Columbia University · Sites in United States, Brazil, Canada and 2 more countries
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 287 Brain Injuries, Traumatic studies recruiting now, 126 (44%) set no upper age limit and 119 (41%) stop at 75 or younger; 41 take children under 18; 53 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
909 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 65 · Phase 2 110 · Phase 3 39 · Phase 4 28
First in 1996; this study’s year is marked. 53 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 150 is above the median of 116 across 558 observational studies indexed under Brain Injuries, Traumatic.
Median enrollment 50 across the 650 interventional studies, 120 across the 257 observational. Of the 553 that completed or were terminated, 182 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
101 of 909 have an industry lead sponsor. The 10 most frequent:
Rehabilitation Hospital of Indiana is the lead sponsor of 6 studies on the registry; none are open to participants now.
Rehabilitation Hospital of Indiana has 5 studies filed under Brain Injuries, Traumatic — fewer than ten, so there is no comparison to draw.
83 of the studies in Brain Injuries, Traumatic with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06368648CoMind Technologies LimitedCoMind Early Feasibility Study | 2026-11 |
| NCT06103201University of Maryland, BaltimoreHyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury | 2026-11-26 |
| NCT07733284Kessler FoundationHome-Based Walking for Thinking Skills in Persons With TBI | 2026-12 |
| NCT06228391Minneapolis Veterans Affairs Medical CenterKetamine Treatment for PTSD and MDD in TBI | 2026-12 |
| NCT05702138Craig HospitalHigh Intensity Step Training After Traumatic Brain Injury | 2026-12 |
Add all 83 to your calendar (.ics) → With an account.
Among the 909 studies in Brain Injuries, Traumatic with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to validate the Brain Injury Self-Efficacy Scale as a measure of self-efficacy in brain injury by comparing it with other measures of self-efficacy, the GSE, and PROMIS self-efficacy.
Brain injury (BI) can be a devastating experience for many survivors, resulting in chronic difficulties in social, emotional, and physical functioning (Landau \& Hissett, 2008). Emotional and neurobehavioral challenges of those with brain injuries often have a direct relationship with their overall rehabilitation outcome. In order to provide patients and caregivers greater support and teach adaptive coping strategies, researchers designed and studied a coping skills group specifically for brain injury survivors and their caregivers at the Rehabilitation Hospital of Indiana (RHI) called the Brain Injury Coping Skills group (BICS). BICS is a 12-session (one session per week), manualized, cognitive-behavioral treatment group designed to provide support, coping skills, and psychoeducation aimed to improve perceived self-efficacy (PSE) and emotional functioning.
Perceived self-efficacy (PSE) is the belief or confidence in one's ability to deal with the challenges related to a specific situation (e.g., brain injury). PSE has been found to be strongly linked to social participation, increased positive regard toward the caregiving role, and was found to be the greatest contributing factor to predicting life satisfaction. Multiple human functions including thought patterns, decisions, motivations, and resiliency are regulated by self-efficacy. PSE also predicts whether an individual can adapt successfully in stressful situations. Cicerone and Azulay found that the greatest contribution to predicting life satisfaction was the person's PSE for managing their cognitive challenges.
Various self-efficacy measures exist. The General Self-Efficacy Scale (GSE) assesses general self-efficacy of the general adult population and adolescents over the age of 12. Additionally, the Patient-Reported Outcomes Measurement Information System (PROMIS) General Self-Efficacy questionnaire that measures an individual's ability to manage various situations, problems, and events, focusing on general life events, as well as social interactions and emotions.
Self-efficacy has been linked with more positive and successful outcomes for brain injury survivors. While low PSE often leads to feelings of depression, anxiety, and avoidance, high self-efficacy often allows points to feelings of more control over one's environment, as well as having a more outward focus on a task, rather than dwelling on themselves and their problems/difficulties. Benight \& Bandura noted that self-efficacy is often a predictor in the ability for trauma-survivors to manage their past traumatic experiences. For instance, in combat veterans diagnosed with PTSD, the implementation of self-efficacy exercises reduced stress and anxiety; therefore, these veterans were better able to manage more stressful situations.
Brain injury survivors and their caregivers face unique challenges after the injury, often experiencing difficulties with coping; therefore, it is important that these survivors and their caregivers have positive perceived self-efficacy for better treatment outcomes. Seeing this as a need, the authors of BICS developed the Brain Injury Self-Efficacy Scale which measures perceived self-efficacy in survivors of brain injury and their caregivers. This measure targets this specific population, as they face these unique challenges involving the brain injury (e.g., coping with their injury, and understanding and explaining their injury). The BI Self-Efficacy Scale provided insight to the needs of BI survivors and their caregivers involving self-efficacy; however, it is necessary to validate this measure in order for it to be evidence-based for other survivors of brain injury.
The purpose of this study is to validate the Brain Injury Self-Efficacy Scale as a measure of self-efficacy in brain injury by comparing it with other measures of self-efficacy, the GSE, and PROMIS self-efficacy.
Participants are survivors of traumatic or acquired brain injury who are coming into RHI for neuropsychological testing.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
- present with receptive/expressive aphasia preventing them from comprehending the questions or responding appropriately
Traumatic or acquired brain injury survivors, patients of RHI
Diagnostic Test: BICS Q
assess perceived self-efficacy (PSE) regarding a person's brain injury and proved responsive to treatment effects in the original BICS study.15-16 Specifically, it measures a person's perceptions about his or her ability to both understand the effects of brain injury, as well as, perceived capability of managing BI-related challenges. As the literature suggests, it is important to utilize a measure that would assess PSE specific to the person's challenge, rather than a general PSE scale.
Brain Injury Self-Efficacy Scale (BICS-Q)
This measures assesses perceived self-efficacy (PSE) regarding a person's brain injury. The scale ranges from 0 (Not at all confident) to 4 (Extremely confident). This measure provides a total score in which higher scores mean greater self-efficacy.
Time frame: Baseline
Patient-reported Outcome Measurement Information System (PROMIS): Self-efficacy for managing symptoms
This measures a person's confidence in managing one's daily activities, emotions, medications/treatments, social interactions, and symptoms. Participants rate how confident they feel about various statements, rating them from 1 (I am not confident at all) to 5 (I am very confident). Higher scores mean higher reported self-efficacy for managing their symptoms.
Time frame: Baseline
The General Self-Efficacy Scale (GSE)
This measures assesses general self-efficacy of the general adult population and adolescents over the age of 12. Participants respond to each statement by determining how true it is to their life, using the following scale: Not true at all (1), Hardly true (2), Moderately true (3), Exactly true (4). Scores are totaled and the higher the score, the greater self-efficacy the individual reports.
Time frame: Baseline
Plan to share: No
No publications or documents are linked to this record.
Ran from Apr 2019 to primary completion in Jun 2023, 50 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rehabilitation Hospital of Indiana